Wellnex Life Limited engages in the manufacture and distribution of health and wellness products in Australia.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.10|
|52 Week High||AU$0.097|
|52 Week Low||AU$0.17|
|1 Month Change||-9.09%|
|3 Month Change||-16.67%|
|1 Year Change||n/a|
|3 Year Change||-89.47%|
|5 Year Change||n/a|
|Change since IPO||-50.00%|
Recent News & Updates
|WNX||AU Food||AU Market|
Return vs Industry: Insufficient data to determine how WNX performed against the Australian Food industry.
Return vs Market: Insufficient data to determine how WNX performed against the Australian Market.
Stable Share Price: WNX is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: Insufficient data to determine WNX's volatility change over the past year.
About the Company
Wellnex Life Limited engages in the manufacture and distribution of health and wellness products in Australia. It offers Uganic branded organic nutritional milk products; Simply 7 branded lentil chips; iron gummies; Wakey Wakey branded energy gummies; Little Innoscents branded organic baby skincare products; Wagner Liquigesic branded soft gel ibuprofen + paracetamol; Compeed branded plasters; EllaOne branded contraception medicine; and Performance Inspired branded nutrition and supplements products, as well as aromatherapy essential oils and domestic cleaning products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021.
Wellnex Life Fundamentals Summary
|WNX fundamental statistics|
Is WNX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|WNX income statement (TTM)|
|Cost of Revenue||AU$1.36m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.081|
|Net Profit Margin||-1,721.62%|
How did WNX perform over the long term?See historical performance and comparison
Is Wellnex Life undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Wellnex Life is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Wellnex Life has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
How is Wellnex Life forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Food, Beverage & Tobacco industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wellnex Life has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Wellnex Life performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: WNX is currently unprofitable.
Growing Profit Margin: WNX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: WNX is unprofitable, and losses have increased over the past 5 years at a rate of 45.2% per year.
Accelerating Growth: Unable to compare WNX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: WNX is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (45.2%).
Return on Equity
High ROE: WNX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is Wellnex Life's financial position?
Financial Position Analysis
Short Term Liabilities: WNX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: WNX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: WNX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: WNX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WNX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: WNX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.3% each year
What is Wellnex Life current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate WNX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate WNX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if WNX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if WNX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of WNX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. George Karafotias, B.Com., serves as Chief Financial Officer of Wellnex Life Limited (formerly known as Wattle Health Australia Limited) and served as its Company Secretary until April 11, 2019. Mr. Ka...
CEO Compensation Analysis
Compensation vs Market: George's total compensation ($USD264.13K) is about average for companies of similar size in the Australian market ($USD301.95K).
Compensation vs Earnings: George's compensation has increased whilst the company is unprofitable.
Experienced Management: WNX's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Experienced Board: WNX's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.3%.
Wellnex Life Limited's employee growth, exchange listings and data sources
- Name: Wellnex Life Limited
- Ticker: WNX
- Exchange: ASX
- Founded: 2011
- Industry: Packaged Foods and Meats
- Sector: Food, Beverage & Tobacco
- Market Cap: AU$30.331m
- Shares outstanding: 303.31m
- Website: https://wellnexlife.investorportal.com.au
- Wellnex Life Limited
- Building 2
- Level 3
- Port Melbourne
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/19 15:54|
|End of Day Share Price||2021/10/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.